# TRADD

## Overview
TRADD (TNFRSF1A-associated via death domain) is a gene that encodes a pivotal adaptor protein involved in the tumor necrosis factor receptor 1 (TNFR1) signaling pathway. The TRADD protein plays a crucial role in mediating cellular responses such as apoptosis and the activation of the transcription factor NF-κB, which are essential for immune response and inflammation (Hsu1995The). As an adaptor protein, TRADD interacts with the death domain of TNFR1, facilitating the recruitment of other signaling proteins, including TRAF2 and c-IAP1, to form complexes necessary for downstream signaling events (Shu1996The). The protein is primarily active in the cytoplasm and is involved in recruiting molecules like FADD and RIPK1, which are critical for determining cell fate (Aggarwal2003Signalling). TRADD's involvement extends to the regulation of pro-inflammatory mediators, highlighting its role in inflammatory responses and cellular processes related to labor and delivery in the human myometrium (Lim2017TRADD).

## Structure
The TRADD protein is a 34 kDa human adaptor protein involved in cell signaling pathways, particularly in NF-kB activation and apoptosis. It consists of two main domains: the N-terminal domain (NTD) and the C-terminal death domain (DD), connected by an unstructured peptide of approximately 37 amino acids (Li2020Functional; Zhang2017Structure).

The NTD of TRADD has an alpha-beta plait topology, featuring four antiparallel beta strands forming a beta sheet and six alpha helices packed against one side of the sheet. This domain is primarily responsible for binding TRAF2 and facilitates interaction with TNFR1-DD (Li2020Functional).

The C-terminal DD of TRADD is unique within the DD superfamily, characterized by a novel fold that includes a beta-hairpin motif flanked by two alpha helices. This motif is essential for the domain's structural integrity and function. The TRADD-DD has a highly charged surface, indicating the importance of electrostatic interactions in its signaling role (Zhang2021Structural; Zhang2017Structure).

TRADD interacts with various proteins through its DD, forming complexes essential for signaling processes like NF-kB activation and apoptosis. However, the exact binding specificity remains largely unknown due to the lack of atomic-level complex structures (Li2020Functional).

## Function
TRADD (TNFRSF1A-associated via death domain) is a crucial adaptor protein involved in the signaling pathways of tumor necrosis factor receptor 1 (TNFR1). In healthy human cells, TRADD plays a significant role in mediating apoptosis and activating the transcription factor NF-κB, which are essential processes for immune response and inflammation (Hsu1995The). TRADD interacts with the death domain of TNFR1, facilitating the recruitment of other signaling proteins such as TRAF2 and c-IAP1 to the TNFR1 complex, which is necessary for downstream signaling events (Shu1996The).

TRADD is involved in the activation of NF-κB, a transcription factor that regulates genes involved in cell survival and inflammation. This activation can occur independently of apoptosis, indicating that TRADD has distinct roles in these processes (Hsu1995The). The protein is primarily active in the cytoplasm and is essential for recruiting other molecules, such as FADD and RIPK1, to form complexes that determine cell fate (Aggarwal2003Signalling).

TRADD's involvement in TNF-α signaling also extends to the regulation of pro-inflammatory mediators and adhesion molecules, highlighting its role in inflammatory responses and cellular processes related to labor and delivery in the human myometrium (Lim2017TRADD).

## Clinical Significance
Mutations or alterations in the expression of the TRADD gene can have significant clinical implications. TRADD is a crucial adaptor protein in the TNF receptor signaling pathway, and its dysfunction can contribute to various diseases. Alterations in TRADD expression or its interactions can disrupt normal cell death and survival mechanisms, potentially leading to cancer, autoimmune disorders, and neurodegenerative diseases (Müllauer2001Mutations).

In the context of antiviral immune responses, TRADD plays a vital role in the RIG-I-like helicase (RLH) pathway. Its interaction with TRAF3 and TANK is essential for activating IRF3, which is crucial for type I interferon responses. TRADD knockdown has been shown to enhance vesicular stomatitis virus replication and impair IFN-b responses, indicating its importance in antiviral defense (Michallet2008TRADD). The hepatitis C virus targets TRADD to inhibit NF-kB signaling, suggesting that TRADD's disruption can facilitate viral persistence (Michallet2008TRADD).

TRADD is also involved in TNFα-induced apoptosis and inflammatory responses. TRADD deficiency can lead to resistance to TNFα-induced cell death and failure to activate NF-kB, which may affect inflammatory disease progression (Chen2008Beyond). These findings highlight the potential impact of TRADD alterations on immune responses and inflammatory diseases.

## Interactions
TRADD (TNFRSF1A-associated via death domain) is a key adaptor protein involved in TNF receptor signaling pathways. It interacts with several proteins, forming multiprotein complexes that are crucial for signaling processes such as apoptosis and NF-kB activation. TRADD interacts with TNF receptor 1 (TNFR1) through its death domain, a process that is TNF-dependent, as demonstrated by coimmunoprecipitation assays (Hsu1996TRADD–TRAF2). This interaction is essential for recruiting other proteins like TRAF2 and FADD to the TNFR1 complex, facilitating the formation of signaling complexes (Hsu1996TRADD–TRAF2).

TRADD's N-terminal region binds to TRAF2, which is critical for NF-kB activation, while its C-terminal death domain interacts with FADD, playing a role in apoptotic signaling (Hsu1996TRADD–TRAF2). The interaction with FADD is particularly important for the formation of complex II, which is associated with apoptosis (Kieser2008Pursuing). TRADD also interacts with RIP1, which is involved in both apoptotic and necrotic pathways, highlighting its role in determining cell fate (Kieser2008Pursuing).

TRADD's interactions are not limited to TNFR1 signaling. It also interacts with the Epstein-Barr virus oncoprotein LMP1, leading to a unique type of NF-kB signaling that bypasses its apoptotic potential (Kieser2008Pursuing). These interactions underscore TRADD's versatility in modulating various signaling pathways.


## References


[1. (Kieser2008Pursuing) Arnd Kieser. Pursuing different ‘traddes’: tradd signaling induced by tnf-receptor 1 and the epstein-barr virus oncoprotein lmp1. bchm, 389(10):1261–1271, August 2008. URL: http://dx.doi.org/10.1515/BC.2008.144, doi:10.1515/bc.2008.144. This article has 42 citations.](https://doi.org/10.1515/BC.2008.144)

[2. (Hsu1996TRADD–TRAF2) Hailing Hsu, Hong-Bing Shu, Ming-Gui Pan, and David V Goeddel. Tradd–traf2 and tradd–fadd interactions define two distinct tnf receptor 1 signal transduction pathways. Cell, 84(2):299–308, January 1996. URL: http://dx.doi.org/10.1016/s0092-8674(00)80984-8, doi:10.1016/s0092-8674(00)80984-8. This article has 1567 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/s0092-8674(00)80984-8)

[3. (Aggarwal2003Signalling) Bharat B. Aggarwal. Signalling pathways of the tnf superfamily: a double-edged sword. Nature Reviews Immunology, 3(9):745–756, September 2003. URL: http://dx.doi.org/10.1038/nri1184, doi:10.1038/nri1184. This article has 2063 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nri1184)

[4. (Chen2008Beyond) Nien-Jung Chen, Iok In Christine Chio, Wen-Jye Lin, Gordon Duncan, Hien Chau, David Katz, Huey-Lan Huang, Kelly A. Pike, Zhenyue Hao, Yu-Wen Su, Kazuo Yamamoto, Renée F. de Pooter, Juan Carlos Zúñiga-Pflücker, Andrew Wakeham, Wen-Chen Yeh, and Tak W. Mak. Beyond tumor necrosis factor receptor: tradd signaling in toll-like receptors. Proceedings of the National Academy of Sciences, 105(34):12429–12434, August 2008. URL: http://dx.doi.org/10.1073/pnas.0806585105, doi:10.1073/pnas.0806585105. This article has 87 citations.](https://doi.org/10.1073/pnas.0806585105)

[5. (Shu1996The) Hong-Bing Shu, Masahiro Takeuchi, and David V. Goeddel. The tumor necrosis factor receptor 2 signal transducers traf2 and c-iap1 are components of the tumor necrosis factor receptor 1 signaling complex. Proceedings of the National Academy of Sciences, 93(24):13973–13978, November 1996. URL: http://dx.doi.org/10.1073/pnas.93.24.13973, doi:10.1073/pnas.93.24.13973. This article has 341 citations.](https://doi.org/10.1073/pnas.93.24.13973)

[6. (Zhang2021Structural) Ning Zhang, Lilian Kisiswa, Ajeena Ramanujan, Zhen Li, Eunice Weiling Sim, Xianbin Tian, Wensu Yuan, Carlos F. Ibáñez, and Zhi Lin. Structural basis of nf-κb signaling by the p75 neurotrophin receptor interaction with adaptor protein tradd through their respective death domains. Journal of Biological Chemistry, 297(2):100916, August 2021. URL: http://dx.doi.org/10.1016/j.jbc.2021.100916, doi:10.1016/j.jbc.2021.100916. This article has 9 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jbc.2021.100916)

[7. (Li2020Functional) Zhen Li, Wensu Yuan, and Zhi Lin. Functional roles in cell signaling of adaptor protein tradd from a structural perspective. Computational and Structural Biotechnology Journal, 18:2867–2876, 2020. URL: http://dx.doi.org/10.1016/j.csbj.2020.10.008, doi:10.1016/j.csbj.2020.10.008. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.csbj.2020.10.008)

[8. (Hsu1995The) Hailing Hsu, Jessie Xiong, and David V. Goeddel. The tnf receptor 1-associated protein tradd signals cell death and nf-κb activation. Cell, 81(4):495–504, May 1995. URL: http://dx.doi.org/10.1016/0092-8674(95)90070-5, doi:10.1016/0092-8674(95)90070-5. This article has 1532 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/0092-8674(95)90070-5)

[9. (Müllauer2001Mutations) Leonhard Müllauer, Petra Gruber, David Sebinger, Judith Buch, Sabine Wohlfart, and Andreas Chott. Mutations in apoptosis genes: a pathogenetic factor for human disease. Mutation Research/Reviews in Mutation Research, 488(3):211–231, July 2001. URL: http://dx.doi.org/10.1016/s1383-5742(01)00057-6, doi:10.1016/s1383-5742(01)00057-6. This article has 294 citations.](https://doi.org/10.1016/s1383-5742(01)00057-6)

[10. (Zhang2017Structure) Ning Zhang, Wensu Yuan, Jing-Song Fan, and Zhi Lin. Structure of the c-terminal domain of tradd reveals a novel fold in the death domain superfamily. Scientific Reports, August 2017. URL: http://dx.doi.org/10.1038/s41598-017-07348-9, doi:10.1038/s41598-017-07348-9. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-017-07348-9)

[11. (Michallet2008TRADD) Marie-Cécile Michallet, Etienne Meylan, Maria A. Ermolaeva, Jessica Vazquez, Manuele Rebsamen, Joseph Curran, Hendrik Poeck, Michael Bscheider, Gunther Hartmann, Martin König, Ulrich Kalinke, Manolis Pasparakis, and Jürg Tschopp. Tradd protein is an essential component of the rig-like helicase antiviral pathway. Immunity, 28(5):651–661, May 2008. URL: http://dx.doi.org/10.1016/j.immuni.2008.03.013, doi:10.1016/j.immuni.2008.03.013. This article has 261 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.immuni.2008.03.013)

12. (Lim2017TRADD) Ref Lim2017<scp>TRADD<scp>. This article has 12 citations and is from a peer-reviewed journal.